Company Update: Pfizer Inc (NYSE:PFE) – IBM Teams Up With Pfizer To Move Towards Parkinson’s Cure

[Benzinga] – International Business Machines Corp. (NYSE: IBM ) and Pfizer Inc. (NYSE: PFE ) announced on Thursday a collaboration to develop monitoring solutions aimed at transforming how health care providers deliver … Read more on this. Pfizer Inc. (PFE) , valued at $202.29B, opened this morning at $32.55. Looking at today’s market, PFE one day range is $32.50 to $33.08 with a trailing 52-week range being $28.25 to $36.46. Priced at 14.38x this year’s forecasted earnings, PFE shares are relatively expensive compared to the industry’s -2.39x forward p/e ratio. And for income investors, the company pays shareholders $1.20 per share annually in dividends, yielding 3.91%. According to a consensus of 16 analysts, the earnings estimate of $0.54 per share would be $0.03 better than the year-ago quarter and a $0.03 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $2.29 is a $0.09 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $11.90 Billion. If reported, that would be a 9.58% increase over the year-ago quarter. Recently, Sun Trust Rbsn Humphrey upgraded PFE from Reduce to Neutral (Nov 25, 2015). Previously, Morgan Stanley upgraded PFE from Equal-Weight to Overweight. The average price target for PFE shares is $38.47, which is 18.19% above where the stock opened this morning. See more in (NYSE:PFE) Similar Articles: Market Update: Pfizer Inc (NYSE:PFE) – Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO Company Update: Pfizer Inc (NYSE:PFE) – Indian court grants Pfizer temporary relief on cough syrup ban